Feb. 6, 2013
/PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that President and Chief Executive Officer
, the Company's Executive Vice President and Chief Financial Officer, will participate in the Leerink Swann Global Healthcare Conference 2013 in
New York City
The event, which will be conducted in a "fireside chat" format, is scheduled for
12:00 p.m. (ET) Wednesday, February 13
. Both live and archived audio webcasts of the event will be accessible through a link on the
section of the Company's website,
About Cynosure, Inc.
develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, remove multi-colored tattoos, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite and treat onychomycosis.
include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit
Scott Solomon Vice President Sharon Merrill Associates, Inc. 617.542.5300
SOURCE Cynosure, Inc.